Reply

Paul D. Griffiths*

Department of Virology, Royal Free and University College Medical School, Royal Free Campus, Rowland Street, London NW3 2PF, UK

Sir,

Dr Crowley’s letter1 illustrates the problems that congenital cytomegalovirus can cause. I agree that treatment should be used where this is supported by evidence-based medicine.

I have recommended the treatment of neonates born with CNS signs since Kimberlin et al.2 presented the abstract of their phase III study. This treatment recommendation and further details can be found on the website of the Clinical Virology Network (clinical-virology.org).

Footnotes

* Tel: +44-207-830-2997; Fax: +44-207-830-2854; E-mail: p.griffiths{at}rfc.ucl.ac.uk Back

References

1 . Crowley, B. (2002). Ganciclovir treatment of symptomatic congenital cytomegalovirus infection. Journal of Antimicrobial Chemotherapy 50, 435–436.[Free Full Text]

2 . Kimberlin, D. W., Lin, C. Y., Sanchez, P., Demmler, G., Dankner, W., Shelton, M. et al. (2000). Ganciclovir (GCV) treatment of symptomatic congenital cytomegalovirus (CMV) infections: results of a phase III randomized trial. In Program and Abstracts of the Fortieth Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Canada, 2000. Abstract 1942, p. 274. American Society for Microbiology, Washington, DC, USA.





This Article
Extract
FREE Full Text (PDF)
Alert me when this article is cited
Alert me if a correction is posted
Services
Email this article to a friend
Similar articles in this journal
Similar articles in PubMed
Alert me to new issues of the journal
Add to My Personal Archive
Download to citation manager
Disclaimer
Request Permissions
Google Scholar
Articles by Griffiths, P. D.
PubMed
PubMed Citation
Articles by Griffiths, P. D.